These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Confined to a tokenistic status: Social scientists in leadership roles in a national health research funding agency. Albert M; Laberge S Soc Sci Med; 2017 Jul; 185():137-146. PubMed ID: 28578211 [TBL] [Abstract][Full Text] [Related]
25. Biotech venture capital--it's not too late to be early. Klausner A Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662 [No Abstract] [Full Text] [Related]
26. Trends in biopharmaceutical IPOS: 1996-2005. Williams DR; Young CC J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239 [TBL] [Abstract][Full Text] [Related]
27. Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector. Paul MJ; Thangaraj H; Ma JK Plant Biotechnol J; 2015 Oct; 13(8):1209-20. PubMed ID: 26140440 [TBL] [Abstract][Full Text] [Related]
28. Financing the health care Internet. Robinson JC Health Aff (Millwood); 2000; 19(6):72-88. PubMed ID: 11192423 [TBL] [Abstract][Full Text] [Related]
30. Snaring a venture capital investment. Lytton M Nat Biotechnol; 1998 May; 16 Suppl():54. PubMed ID: 9591272 [No Abstract] [Full Text] [Related]
31. Regenerative medicine in Europe: global competition and innovation governance. Hogarth S; Salter B Regen Med; 2010 Nov; 5(6):971-85. PubMed ID: 21082895 [TBL] [Abstract][Full Text] [Related]
32. The role of the private sector in biotechnology: research and development. Feisee L Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359 [No Abstract] [Full Text] [Related]
33. Decoding DNA data storage for investment. Stanley PM; Strittmatter LM; Vickers AM; Lee KCK Biotechnol Adv; 2020 Dec; 45():107639. PubMed ID: 33002583 [TBL] [Abstract][Full Text] [Related]
35. Health care technology in Canada (with special reference to Quebec). Battista RN; Jacob R; Hodge MJ Health Policy; 1994; 30(1-3):73-122. PubMed ID: 10139497 [TBL] [Abstract][Full Text] [Related]
36. My worst biotech investment. Jacobs T Nat Biotechnol; 2006 Apr; 24(4):401. PubMed ID: 16601718 [No Abstract] [Full Text] [Related]
37. Intellectual property as a foundation for funding. Meltzer SL; Marks MS; McCormick JT Nat Biotechnol; 2002 Jul; 20 Suppl():BE47-50. PubMed ID: 12089588 [No Abstract] [Full Text] [Related]
38. Is small really beautiful? Some thoughts on the 1995 federal budget. Hurley J; Bhatia V; Markham B Leadersh Health Serv; 1995; 4(3):12-5, 18. PubMed ID: 10142922 [TBL] [Abstract][Full Text] [Related]
40. The socio-economic landscape of biotechnology in Spain. A comparative study using the innovation system concept. Díaz V; Muñoz E; de los Monteros JE; Senker J J Biotechnol; 2002 Sep; 98(1):25-40. PubMed ID: 12126803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]